Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression

Trial Profile

Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Jul 2017

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top